Dr. Perera has over 25 years clinical research experience. He has been responsible for the development and approval of small molecule drugs for a variety of CNS and pain disorders. Prior to joining EmbarkNeuro Dr. Perera held senior level clinical, scientific, management and business development positions at GlaxoSmithKline, Pharmacia Upjohn, Jazz Pharmaceuticals, Pfizer, the Parkinson’s Institute and Longboard Pharmaceuticals. He is a graduate of Harvard Medical School and a board-certified Psychiatrist. He also holds a Masters degree in Business Administration from Arizona State University. Prior to working in the pharmaceutical industry Dr. Perera was on the faculty of New York Hospital, Cornell Medical College as Chief of Inpatient and Day Treatment Psychiatric Services at North Shore University Hospital, and he was a practicing adult and geriatric psychiatrist. Dr. Perera has published numerous clinical research papers and is a former Board member of the American Society for Experimental NeuroTherapeutics.
Phil Perera, MD
Chief Medical Officer